SCPH — SCPHARMACEUTICALS INC

Ownership history in Tejara Capital Ltd  ·  9 quarters on record

This page tracks every 13F SEC filing in which Tejara Capital Ltd reported a position in SCPHARMACEUTICALS INC (SCPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.99% (2023 Q4)
Avg. % of fund
1.12%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 245,209 -252,521 -50.7% 0.73% $1.4M —
2025 Q2 REDUCED 497,730 -164,322 -24.8% 0.88% $1.9M —
2025 Q1 ADDED 662,052 +49,202 +8.0% 0.67% $1.7M —
2024 Q4 REDUCED 612,850 -37,415 -5.8% 1.42% $2.2M —
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding SCPH

As of 2025 Q3 — sorted by position size

Yakira Capital Management, Inc. 3Y 7Y 0.87% ORBIMED ADVISORS LLC 3Y 7Y 0.81% Newtyn Management, LLC 3Y 7Y 0.65% APIS CAPITAL ADVISORS, LLC 3Y 7Y 0.55% Rangeley Capital, LLC 0.46% Balanced Rock Investment Advisors LLC 0.34% ALPINE ASSOCIATES MANAGEMENT INC. 3Y 7Y 0.33% Rubric Capital Management LP 3Y 7Y 0.33% GABELLI & Co INVESTMENT ADVISERS, INC. 3Y 7Y 0.28% GLAZER CAPITAL, LLC 3Y 7Y 0.26%
← Back to Tejara Capital Ltd Holdings